Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-based pathomics in kidney diseases: progress and application
1
Zitationen
9
Autoren
2025
Jahr
Abstract
In recent years, artificial intelligence (AI) has advanced significantly in the field of pathomics, enabling the transformation of pathological images into high-throughput, machine-readable datasets for quantitative analysis and precise diagnosis in renal pathology. AI-based pathomics has introduced innovative perspectives and sophisticated tools for detecting glomerular injury, evaluating renal interstitial fibrosis, monitoring transplanted kidney pathology longitudinally, and predicting outcomes in renal tumors. Despite its great promise, the application of AI-based pathomics in nephrology still faces several challenges, including complex data annotation, limited model interpretability, lack of comprehensive multi-modal data integration, and insufficient large-scale clinical validation. Future research should prioritize these challenges by enhancing multi-omics integration and promoting interdisciplinary collaboration, thereby advancing AI-based pathomics in nephrology and ultimately improving the precision and efficiency of patient care.
Ähnliche Arbeiten
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.271 Zit.
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
2013 · 6.527 Zit.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
2015 · 5.832 Zit.
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 · 5.723 Zit.
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · 4.766 Zit.